Up-regulation of SNHG20 has been validated in several kinds of tumors, including non-small-cell lung cancer, colorectal cancer, gastric cancer, and bladder cancer [3, 15, 28]. This evidence concerns the gene SNHG20 and urinary bladder carcinoma.